Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis
about
Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasisAngiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1Microvascular complications and diabetic retinopathy: recent advances and future implicationsThe vasohibin family: a novel family for angiogenesis regulationRole of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formationGenome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European AmericansVasohibins: new transglutaminase-like cysteine proteases possessing a non-canonical Cys-His-Ser catalytic triadVasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo.FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression.Vasohibin 2 as a potential predictor of aggressive behavior of triple-negative breast cancer.Vasohibin‑2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor‑2 and growth/differentiation factor‑15 expressionVasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.Angiogenesis and chronic kidney disease.Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstructionVasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysisEnhanced cancer metastasis in mice deficient in vasohibin-1 gene.Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular MatrixInhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma CellsVasohibin-1 suppresses colon cancer.The genetic regulation of the terminating phase of liver regeneration.Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells.Exercise training and peripheral arterial disease.Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis.Age-associated downregulation of vasohibin-1 in vascular endothelial cellsVasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis.Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.Expression and localization of members of the thrombospondin family during final follicle maturation and corpus luteum formation and function in the bovine ovary.Knockout of Vasohibin-1 Gene in Mice Results in Healthy Longevity with Reduced Expression of Insulin Receptor, Insulin Receptor Substrate 1, and Insulin Receptor Substrate 2 in Their White Adipose Tissue.Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2.Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy.Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.Distinctive role of vasohibin-1A and its splicing variant vasohibin-1B in tumor angiogenesis.The Vasohibin Family.In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer.Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs.MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells.
P2860
1f972c6c4f5d86e433c2c8644ebd2d91e3daab2e32a32c1f279181abf264713121aef026fb96ad1158e9a7b4d416a3b8122a4f84d202530c4eda46836ee4f9a14e132c240ce017e57a6f2e6ddf483973a8c6e32f1bfbedcc809b2ec423b7881f54d981a7aae595515fa4b82f5355df837424e6e5b63b10f6c1b62efbeadd235a8d5f6c51294132aad02fcf87fda816a1057314d1292a88086689718b4e8ae1eb
P248
Q24298455-13291402-14D0-45BA-9D2F-803ACEBE8AD8Q24300671-14F204E5-F05E-4AD4-B624-36BC4C0A147CQ26822476-08A3BF57-CBED-40D3-996C-03930101F436Q27013978-59B9131A-44A0-4D8A-AA0F-06303947642AQ28117720-E13DE44A-0FD4-406B-A7D0-720559DCEC06Q28943456-A62FA070-17E5-4026-8930-6D575AAAD743Q30383716-9BA23491-EA8D-4722-856D-0EE69ECA2FDBQ33493619-8EDF9D58-6618-4925-A814-6BC7757C161EQ33816926-C845C9D5-043A-45F5-B7FA-15A44E030C3FQ33850275-4C075923-7749-4217-A68B-F78146670396Q33891210-C9EC385E-998C-4277-AE62-CBB445F75B55Q33960317-F79B79C1-5D49-4E26-88A2-C5765A08CE90Q34075013-988C1A51-CC79-493F-BA85-B86DD7FCF0EFQ34257934-9711BF4C-F609-4BB3-BE1C-C84FBC043DF4Q34333028-F20F5B50-A117-4D20-8695-97CDBBCA171CQ34399941-78500064-AA69-4B99-A3F2-CCBB571363B9Q34550067-279C7829-C97F-4990-A541-E814C6576EEAQ34997149-34AA7F91-336E-4D1F-99A9-695F5D17E1CDQ35111116-060E80D5-19B7-4DD6-ABB0-ADD50BF75AF6Q35679807-9FEF7D22-99D7-4BEF-B0B3-6E2B8A472CB2Q35770798-8429ACE8-5DF6-4688-A5CF-CA439B6FD073Q35781453-E782BD6B-7A0C-424E-A958-513F4BB5C0E3Q36572140-622041FD-F0B6-4516-B356-5E47FC3DEAE5Q36621362-B9FDCCD5-D140-4703-91D8-0438F1794773Q37157213-62769755-1221-4958-A401-79E4BF704220Q37173668-572CCAED-2785-432A-9FD6-EAAAEF725A2CQ37235618-5679DD6B-5B60-4420-ACEA-7E10D238CF4CQ37257230-CF9ED610-CCCD-412D-9072-3BD500CB22EBQ37360457-D3108A95-A6A5-4DFC-A4A0-5FD98ADFD850Q37369734-56D371DD-B29C-47F8-9951-63405D59E098Q37711724-AB8F9F24-6535-4D74-9009-9BAF19785E0AQ37713632-9E6EDF9D-1DE8-40F5-8F5A-7DFD4C98F0A8Q37735605-398B3DE6-89CE-4F38-83E6-C2805767921FQ37852794-19D9E56C-AF82-44FC-8960-DA31279197DAQ38722425-1F2079DB-8B87-4E9E-93B5-857EEDD7B2C5Q38778140-D796B3B9-8542-43C4-AB65-1489BCDD0238Q38974184-E29A5B22-A21F-4E17-88B4-1D41A955FF54Q39080600-1F92E6E5-78AF-4EBA-8B46-BB12424969BCQ39375805-5241F5DA-5428-4D5C-8304-3A64331E9DF2Q40977772-BA9735AF-80BF-406A-8F84-42BAA3A9A0E0
P2860
Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Distinctive localization and o ...... the regulation of angiogenesis
@ast
Distinctive localization and o ...... the regulation of angiogenesis
@en
Distinctive localization and o ...... the regulation of angiogenesis
@en-gb
Distinctive localization and o ...... the regulation of angiogenesis
@nl
type
label
Distinctive localization and o ...... the regulation of angiogenesis
@ast
Distinctive localization and o ...... the regulation of angiogenesis
@en
Distinctive localization and o ...... the regulation of angiogenesis
@en-gb
Distinctive localization and o ...... the regulation of angiogenesis
@nl
prefLabel
Distinctive localization and o ...... the regulation of angiogenesis
@ast
Distinctive localization and o ...... the regulation of angiogenesis
@en
Distinctive localization and o ...... the regulation of angiogenesis
@en-gb
Distinctive localization and o ...... the regulation of angiogenesis
@nl
P2093
P921
P3181
P1433
P1476
Distinctive localization and o ...... the regulation of angiogenesis
@en
P2093
Hideki Ohta
Hikaru Sonoda
Hiroki Miyashita
Hiroshi Kimura
Kazuhide Watanabe
Miho Kobayashi
Takashi Fujiwara
Tooru Shimosegawa
Yasufumi Sato
Yasuhiro Suzuki
P304
P3181
P356
10.1182/BLOOD-2008-07-170316
P407
P577
2009-05-07T00:00:00Z